Clinical Psychopharmacology · Paper A
Tolerance and cross-tolerance
Cross-toleranceNeeding a larger dose of a drug over time to get the same effect.Read more → explains a strange bedside finding: alcohol dependence predicting an unexpectedly high anaesthetic dose requirement in surgery, because tolerance built to one drug can blunt response to a completely different drug acting on the same receptor system. Tolerance itself is simply a reduction in drug response with repeated exposure, needing a higher dose for the same effect. A patient dependent on alcohol, e.g. someone requiring a markedly higher anaesthetic dose than expected during surgery, shows exactly this pattern: their alcohol tolerance has produced cross-tolerance to the anaesthetic, since both act through the same GABA-A receptorA receptor for the calming brain chemical GABA, and the site where benzodiazepines and alcohol produce their sedating effect.Read more →.
Pharmacokinetic toleranceNeeding a larger dose of a drug over time to get the same effect.Read more → reflects altered drug disposition, typically liver enzyme inductionA drug increasing the amount or activity of a liver enzyme, which speeds up the breakdown of other drugs it shares that enzyme with.Read more → (e.g. CYP2E1 induction with chronic alcohol use) lowering the concentration reaching the site of action. Pharmacodynamic tolerance instead reflects receptor-level adaptation at an unchanged drug concentration, such as GABA-A receptorA receptor for the calming brain chemical GABA, and the site where benzodiazepines and alcohol produce their sedating effect.Read more → subunit changes with chronic alcohol or benzodiazepine exposure. Tolerance can also develop unevenly across a single drug's effects: with opioids, substantial tolerance develops to analgesia and respiratory depression, but tolerance to constipation is slow and partial. A patient on long-term opioids who now needs a much higher dose for pain relief but still has significant constipation shows this unevenness directly. In practice, tolerance to analgesia does not protect against constipation, so laxatives are still needed even at a tolerant, higher dose.
A fresh doctor might assume is simple: use a drug repeatedly, need more of it. Cross-tolerance is the twist that actually gets tested: adapting to one drug can blunt response to a completely different drug, and that single fact underlies why benzodiazepines are used to treat alcohol withdrawal. Hold the phrase SHARED RECEPTOR, SHARED TOLERANCE through every section below.
is a reduction in drug response with repeated exposure, requiring a higher dose to achieve the same effect. Cross-tolerance is a related but distinct phenomenon: tolerance built up to one drug reduces the response to a different, pharmacologically related drug that acts on the same receptor system, even if that second drug has never been taken before.
A common mistake is confusing with dependence or sensitisation. Physical dependence is defined by a withdrawal syndrome on stopping the drug, not by a blunted response while still taking it: a patient can be dependent without being especially tolerant, and vice versa. Sensitisation (reverse tolerance) is the opposite of tolerance: an enhanced, not reduced, response with repeated intermittent exposure, classically seen with psychostimulants such as amphetamines, where repeated use can eventually provoke paranoia at doses that were previously well tolerated.
can arise through two different mechanisms. Pharmacokinetic tolerance reflects altered drug disposition, typically hepatic , for example CYP2E1 induction with chronic alcohol use, which lowers the drug concentration reaching its site of action. Pharmacodynamic tolerance instead reflects receptor-level adaptation, such as downregulation or desensitisation of (a receptor for the inhibitory ) with chronic alcohol or benzodiazepine exposure, at an unchanged drug concentration.
Alcohol, benzodiazepines, and barbiturates all act, at least partly, through the same , so chronic to one produces cross-tolerance to the others. This is the pharmacological basis for using a benzodiazepine, such as chlordiazepoxide, to manage alcohol withdrawal safely: an alcohol-dependent patient's GABA-A receptors are already adapted, so a benzodiazepine can substitute for alcohol's receptor effect and be tapered down gradually, preventing dangerous withdrawal seizures and delirium tremens (a severe withdrawal state with confusion, tremor, and autonomic instability).
does not develop evenly across all of a single drug's effects. With opioids, substantial tolerance develops to analgesia (pain relief), euphoria, and respiratory depression, but tolerance to constipation is slow and only partial. A patient on long-term opioids who now needs a much higher dose for adequate pain relief but still has significant constipation is showing this unevenness directly: laxatives remain necessary even once the analgesic dose has been titrated well above the starting dose.
Cross- (reduced response to a different but related drug sharing the same receptor mechanism) should not be confused with ordinary tolerance to repeated doses of the same drug. Acute tachyphylaxis is a rapid loss of effect within minutes to hours after only a few doses, distinct from tolerance, which builds gradually over days to weeks. Behavioural (conditioned) tolerance, a learned, cue-dependent reduction in drug effect tied to the context of use, should not be confused with the fixed pharmacokinetic or pharmacodynamic mechanisms described above.
and cross-tolerance are recognised clinically rather than through a laboratory test: a rising dose requirement for the same effect over time, elicited through a careful substance-use history (quantity, frequency, duration, and how the patient's response has changed), is the core evidence. In alcohol withdrawal specifically, the related but distinct question of withdrawal severity is assessed using a structured tool such as the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, revised) scale, which scores symptoms like tremor, sweating, anxiety, and to guide how much benzodiazepine is needed. In perioperative settings, unexpectedly high anaesthetic or sedative requirements in a patient with heavy alcohol or benzodiazepine use should themselves be recognised as a diagnostic clue pointing to underlying cross-tolerance, prompting anticipatory dose adjustment rather than simply escalating reactively.
Management of alcohol withdrawal follows a reducing benzodiazepine regimen guided by NICE and Maudsley Prescribing Guidelines-informed practice, exploiting cross- deliberately as the first-line treatment strategy, alongside thiamine supplementation to prevent . Opioid tolerance management includes proactive, first-line prescribing of laxatives alongside any long-term opioid regimen, regardless of analgesic dose. Recognising cross-tolerance also changes practical prescribing more broadly: a patient with heavy alcohol use disorder may need higher-than-standard doses of anaesthetic or sedative medication for adequate effect, and this should be anticipated and monitored during any procedure rather than discovered mid-way through it.
The high-yield pearl: an unexpectedly high sedative or anaesthetic requirement in a heavy drinker is cross-, not "high pain tolerance." Vignettes often describe an alcohol-dependent patient needing an unexpectedly high anaesthetic or benzodiazepine dose and expect recognition of cross-tolerance via the shared . Another trap describes a long-term opioid patient with well-controlled pain but ongoing constipation and expects recognition that tolerance to different opioid effects develops unevenly, rather than assuming inadequate laxative dosing is unrelated to the opioid regimen. A further trap tests whether candidates can distinguish tolerance (reduced response), sensitisation (increased response), and dependence (withdrawal on stopping) as three separate concepts.
is a reduced drug response requiring a higher dose for the same effect, arising through pharmacokinetic () or pharmacodynamic (receptor adaptation) mechanisms, and is recognised through a substance-use history rather than a lab test. Cross-tolerance extends this to a different drug sharing the same receptor system, such as alcohol and benzodiazepines both acting on , which is why benzodiazepines can substitute for alcohol during withdrawal, with severity tracked using tools like -Ar. Tolerance develops unevenly across a drug's effects, and must be distinguished from sensitisation (an enhanced response) and physical dependence (a withdrawal syndrome), both distinct concepts tested separately.